- Home
- PMTS vs PRQR Comparison
PMTS vs PRQR Comparison
Compare PMTS & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMTS | PRQR |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 183.1M | 250.7M |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PMTS | PRQR |
|---|---|---|
| Price | $17.83 | $2.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $32.00 | $8.14 |
| AVG Volume (30 Days) | 63.2K | ★ 558.5K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.20 | N/A |
| Revenue | ★ $515,576,000.00 | $18,859,556.00 |
| Revenue This Year | $13.70 | N/A |
| Revenue Next Year | $8.51 | N/A |
| P/E Ratio | $14.74 | ★ N/A |
| Revenue Growth | ★ 12.48 | N/A |
| 52 Week Low | $11.64 | $1.07 |
| 52 Week High | $35.19 | $3.46 |
Technical Indicators
Market Signals| Indicator | PMTS | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 69.36 | 53.02 |
| Support Level | $13.03 | $2.15 |
| Resistance Level | $18.23 | $2.43 |
| Average True Range (ATR) | 0.73 | 0.18 |
| MACD | 0.53 | 0.04 |
| Stochastic Oscillator | 90.29 | 76.82 |
Price Performance
Historical ComparisonAbout PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.